Compass Research Phase 1, LLC — Orlando, Florida

Compass Research Phase 1, LLC is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Compass Research Phase 1, LLC has participated in 3 clinical trials.

Therapeutic areas: Cystic Fibrosis, Healthy, Hyperkalemia.

Sponsors: Gilead Sciences, Eisai Inc., ZS Pharma, Inc..

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Research Phase 1, LLC?

Compass Research Phase 1, LLC has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Research Phase 1, LLC conducted?

Compass Research Phase 1, LLC has 3 clinical trials on record. Their work covers Cystic Fibrosis, Healthy, Hyperkalemia.

Is Compass Research Phase 1, LLC accredited by Crixeo Health?

Compass Research Phase 1, LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Compass Research Phase 1, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.